November 18th, 2007 Posted by: Dr. Dobson
An anti-psychotic drug already approved in the U.S. to treat adults and adolescents with schizophrenia may soon be available for youngsters age 10 to 17 years of age suffering from bipolar disorder.
The U.S. Food and Drug Administration (FDA) has given priority review status to the drug Abilify which is manufactured by Bristol-Myers Squibb and Otsuka Pharmaceutical.
Read the rest of this entry »
Popularity: unranked [?]
Tags:
Foamix,
issued,
cosmetic,
pharmaceutical,
patent,
approvals
Posted in Men`s Health, Drugs, Medicine, Lab Medicine, Pediatrics, Pharmacists | No Comments »
September 7th, 2007 Posted by: Dr. Dobson
Conducting clinical trials overseas is nothing new, however, increasing access to capital and investment in emerging countries does appear to be relatively recent. Two new pieces (links at end) detail the move into China by pharmaceutical companies. I have covered this notion in a previous post.
Read the rest of this entry »
Popularity: 5% [?]
Tags:
Trends,
Global,
Pharmaceutical,
Manufacturing,
Investment
Posted in Latest news, Men`s Health, Drugs, Lab Medicine, Pharmacists | No Comments »
June 8th, 2007 Posted by: Dr. Dobson
SACRAMENTO—The Senate Health Committee today passed SB 1683, the Pharmaceutical Drug Right-to-Know Act. The bill, authored by Senator Jack Scott (Alta Dena) and sponsored by CALPIRG, would require drug companies to release the results of all their health studies for every drug sold in California.
Read the rest of this entry »
Popularity: 10% [?]
Tags:
Senate,
Health,
Committee,
Passes,
Groundbreaking,
Pharmaceutical,
Safety,
Legislation
Posted in Men`s Health, Drugs, Medicine, Lab Medicine, Nurses, Pharmacists | No Comments »